Safi Biotherapeutics Inc
Safi Biotherapeutics is an early stage biotech company developing cell therapies from hematopoietic progenitor sources.
http://www.safi.bio
2-10 employees
Growth Trajectory
The company's future growth lies in expanding its manufacturing capabilities, optimizing bioprocessing, and cryostorage, with a focus on developing red blood cells for trauma and tailored red blood cells for specific transfusions like sickle cell disease. The company has secured $5M in seed funding and is collaborating with ARMI | BioFabUSA, signaling potential market expansion.
Technical Challenges
Manufacturing at appropriate scale.
Maintaining high product consistency.
Developing cost-effective manufacturing processes.
Tech Stack
Team Size
Key Risks
Competition from traditional blood donation methods.
Manufacturing at appropriate scale.
Maintaining high product consistency.
Regulatory requirements for cell therapy products.
Developing cost-effective manufacturing processes.
Opportunities
Addressing shortages of specific blood types.
Advancements in cell therapy manufacturing.
Personalized transfusions.
Point-of-need manufacturing for cold weather combat effectiveness.
Collaboration with universities, research institutions, and other biotech companies.
Live Data Stream
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats